Navigation Links
As E-Cigarette Poisoning Reports Rise, Bernstein Liebhard LLP Notes Proposed Legislation Aimed at Preventing Child Poisonings from Electronic Cigarettes
Date:8/8/2014

New York, New York (PRWEB) August 08, 2014

As the Firm continues its investigation of serious health problems that may be attributable to the use of e-cigarettes (http://www.ecigregistry.com/ ), Bernstein Liebhard LLP notes that one Ohio lawmaker has proposed legislation that would subject these products to stricter regulation. According to a report from NewsNet 5 in Cleveland, U.S. Sen. Sherrod Brown (D-Ohio) is sponsoring The Child Nicotine Poisoning Prevention Act, which would make it illegal to market electronic cigarettes to children and require childproof packaging on containers of liquid nicotine or "e-juice”.*

“Concerns about the potentially harmful effects of e-cigarettes have grown in recent months, especially in regards to children. It is not surprising that lawmakers like Senator Brown have taken notice of this important public health issue,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs, medical devices and consumer products. The Firm urges anyone who was hospitalized for nicotine poisoning, pneumonia, heart attacks, strokes, atrial fibrillation, or congestive heart failure that may have been caused by electronic cigarettes to report their experience to its new E-Cigarette Registry as soon as possible.

Electronic Cigarette Regulation
During a news conference held by Senator Brown on July 28th to announce the new legislation, it was noted that Ohio poison control centers had already received some 100 calls this year that were related to accidental liquid nicotine poisonings. Only 20 such calls were logged in the state in 2013. Nationwide, the U.S. Centers for Disease Control (CDC) reported a total of 215 calls to poison control centers about liquid nicotine poisonings in February alone.*

Senator Brown was also among the Democratic lawmakers who recently sent a letter to the U.S. Food & Drug Administration (FDA) asking the agency to ban the marketing of e-cigarettes to minors. Among other things, the August 4th letter pointed to research that suggests exposure to electronic cigarette marketing by children aged 12 to17 increased by 256 percent between 2011 and 2013. The letter also cites a study which found that middle and high school students who used e-cigarettes were more likely to smoke traditional cigarettes and less likely to quit smoking.**

In April, the FDA proposed new rules that would extend its regulatory authority to cover additional products that meet the legal definition of a tobacco product, including electronic cigarettes. Among other things, the new rules would allow the FDA to impose age and identification restrictions on the sale of e-cigarettes. The agency is accepting public comments on its proposal until August 8th. Individuals who wish to comment electronically may do so at http://www.regulations.gov. ***

As part of its e-cigarette investigation, Bernstein Liebhard LLP is seeking to hear from individuals who may have experienced serious adverse health effects due to these products, including hospitalizations for nicotine poisoning, pneumonia, heart attacks, strokes, atrial fibrillation, or congestive heart failure. To report a problem to the Firm’s E-Cigarette Registry, please visit Bernstein Liebhard LLP’s website. Reports may also be made directly to the Firm by calling 800-511-5092.

*newsnet5.com/news/local-news/investigations/e-cigarette-danger-huge-increase-in-accidental-liquid-nicotine-poisonings, NewsNet 5, July 28, 2014
**help.senate.gov/newsroom/press/release/?id=ff437b7e-521a-4b9d-ad55-79d62ec8bfd3&groups=Chair, U.S. Senate, August 4, 2014
***fda.gov/TobaccoProducts/Labeling/ucm388395.htm, FDA, April 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.ecigregistry.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/e-cigarette-injury/electronic-cigarettes/prweb12082774.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Possible Health Effects of E-Cigarettes Prompt Lawmakers to Seek Ban on Electronic Cigarette Marketing to Minors, Bernstein Liebhard LLP Reports
2. Many Doctors Recommend E-Cigarettes as Anti-Smoking Aid, Survey Finds
3. Benefits of E-Cigarettes May Outweigh Harms, Study Finds
4. E-cigarettes far less harmful than cigarettes, says Lancet researcher at INFORMS Conference
5. E-cigarettes: More than just hot air
6. Cool factor separates e-cigarettes from nicotine inhalers
7. E-cigarettes: Not a healthy alternative to smoking
8. E-cigarette use for quitting smoking is associated with improved success rates
9. Study of third hand nicotine from e-cigarette exposure wins NIH Addiction Science Award
10. Fewer smokers believe e-cigarettes are a safer alternative to cigarettes
11. E-cigarettes and mental health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology: